In October, 2016 18 leading brain cancer researchers and clinicians met at Stanford University to discuss opportunities and plans for bringing new treatments to oligodendroglioma. This has laid the groundwork for the Oligo Research Network which will launch its first initiatives to accelerate research in Spring 2017.
